Skip to main content
. Author manuscript; available in PMC: 2021 Jun 9.
Published in final edited form as: Cancer Immunol Immunother. 2020 Oct 30;70(5):1227–1237. doi: 10.1007/s00262-020-02747-w

Table 2.

Primary monoclonal antibodies used for FOXP3, PD-L1, PD-L2, and IDO-1 IHC

Clone Source Staining concentration
FoxP3 236A/E7 Abcam 10 μg/mL
PD-L1 SP142 Spring Bioscience 0.096 ug/mL
PD-L2 F04 Bristol–Myers Squibb 1 μg/mL
IDO-1 SP260 Spring Bioscience 1.19 μg/mL